NCT03355963View on ClinicalTrials.gov

Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) in the Treatment of Erectile Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 12, 2016

Primary Completion Date

January 25, 2019

Study Completion Date

February 20, 2019

Conditions
Erectile DysfunctionBotulinum Toxin
Interventions
OTHER

saline injection

The control group: received an IC 1 ml saline injection one day after the penile Doppler/trimix test.

BIOLOGICAL

Botulinum toxin type A 50 units

The treatment group B: received a single IC injection of BTX-A 50 units one day after the penile Doppler/trimix test.

BIOLOGICAL

Botulinum toxin type A 100 units

The treatment group C: received a single IC injection of BTX-A 100 units one day after the penile Doppler/trimix test.

All Listed Sponsors
collaborator

Cairo University

OTHER

lead

Benha University

OTHER

NCT03355963 - Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) in the Treatment of Erectile Dysfunction | Biotech Hunter | Biotech Hunter